Taho Pharmaceuticals Ltd (6467)

Currency in TWD
2.30
0.00(0.00%)
Closed·
Showing Taho Pharmas historical data. For real-time data please try another search
Day's Range
1.902.82
52 wk Range
0.002.82
Key Statistics
Bid/Ask
5.91 / 6.00
Prev. Close
6.02
Open
2.52
Day's Range
1.9-2.82
52 wk Range
0-0
Volume
-
Average Volume (3m)
58.66M
1-Year Change
0%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Taho Pharmas Company Profile

Taho Pharmaceuticals Ltd., a pharmaceutical company, develops products using transdermal and transmucosal systems in Taiwan. The company’s portfolio includes TAH4411 Ondansetron ODF for the treatment of chemotherapy-induced nausea and vomiting; TAH3311 apixaban oral film, which is in phase 3 clinical trial for patients with Dysphagia; TAH3341 apixaban oral extend release film for patients with Dysphagia; TAH2211 Buprenorphine/Naloxone sublingual film, which is in phase 1 clinical trial for opioid addiction; TAH2231 Naloxone Buccal film , which is in phase 1 clinical trial for opioid overdose; TAH9922 atomoxetine oral liquid, which is in phase 1 clinical trial; and TAH9901 methylphenidate patch, which is in phase 1 clinical trial for the treatment of deficit and hyperactivity disorder. The company was founded in 2010 and is based in Taipei, Taiwan.

Employees
27
Market
Taiwan

Earnings

Latest Release
Apr 23, 2025
EPS / Forecast
-2.00 / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

6467 Income Statement

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.